Cite
MLA Citation
D. Migliorini et al.. “531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results.” European journal of cancer, vol. 51, n.d., pp. S114–. http://access.bl.uk/ark:/81055/vdc_100030628048.0x000063